[
    [
        {
            "time": "2021-07-15",
            "original_text": "医药生物行业周报：海外疫情反复 行业超跌后迎来反弹",
            "features": {
                "keywords": [
                    "医药",
                    "生物",
                    "海外疫情",
                    "反弹"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：海外疫情反复 行业超跌后迎来反弹",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-10",
            "original_text": "【券商聚焦】高盛普升药明康德(02359)及康龙化成(03759)目标价 指上半年CDMO收入增长超预期",
            "features": {
                "keywords": [
                    "高盛",
                    "药明康德",
                    "康龙化成",
                    "CDMO",
                    "收入增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【券商聚焦】高盛普升药明康德(02359)及康龙化成(03759)目标价 指上半年CDMO收入增长超预期",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-12",
            "original_text": "康龙化成(300759)：收入保持高速增长 看好新老业务规模效应提升",
            "features": {
                "keywords": [
                    "康龙化成",
                    "收入",
                    "高速增长",
                    "规模效应"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(300759)：收入保持高速增长 看好新老业务规模效应提升",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-20",
            "original_text": "医药行业2021年中期投资策略：创新为行业长期发展主旋律 聚焦相关高景气、高尖端细分领域",
            "features": {
                "keywords": [
                    "医药",
                    "创新",
                    "长期发展",
                    "高景气",
                    "高尖端"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业2021年中期投资策略：创新为行业长期发展主旋律 聚焦相关高景气、高尖端细分领域",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-15",
            "original_text": "浙商证券：维持康龙化成(300759.SZ)“买入”评级 收入端符合预期 持续看好一体化平台搭建",
            "features": {
                "keywords": [
                    "浙商证券",
                    "康龙化成",
                    "买入",
                    "一体化平台"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "浙商证券：维持康龙化成(300759.SZ)“买入”评级 收入端符合预期 持续看好一体化平台搭建",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-25",
            "original_text": "基金二季报陆续发布，明星基金经理调仓换股",
            "features": {
                "keywords": [
                    "基金",
                    "二季报",
                    "调仓换股"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "基金二季报陆续发布，明星基金经理调仓换股",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-20",
            "original_text": "黄金赛道CXO|药明康德：全产业链龙头，上市3年股价已飙涨15倍！",
            "features": {
                "keywords": [
                    "CXO",
                    "药明康德",
                    "全产业链",
                    "股价飙涨"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "黄金赛道CXO|药明康德：全产业链龙头，上市3年股价已飙涨15倍！",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-25",
            "original_text": "安信证券给予康龙化成买入-A评级：一体化服务平台驱动各项业务快速发展，2021H1业绩增长符合预期",
            "features": {
                "keywords": [
                    "安信证券",
                    "康龙化成",
                    "一体化服务",
                    "业绩增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安信证券给予康龙化成买入-A评级：一体化服务平台驱动各项业务快速发展，2021H1业绩增长符合预期",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-30",
            "original_text": "每日理财观察：基金交易经手费今日下调",
            "features": {
                "keywords": [
                    "基金",
                    "交易经手费",
                    "下调"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "每日理财观察：基金交易经手费今日下调",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-05",
            "original_text": "400家机构紧急组团，调研1500亿市值大牛股",
            "features": {
                "keywords": [
                    "机构",
                    "调研",
                    "市值",
                    "牛股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "400家机构紧急组团，调研1500亿市值大牛股",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-10",
            "original_text": "1500亿牛股闪崩14%! 400家机构紧急组团调研！",
            "features": {
                "keywords": [
                    "牛股",
                    "闪崩",
                    "机构",
                    "调研"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "1500亿牛股闪崩14%! 400家机构紧急组团调研！",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "康龙化成A股跌逾14% 当日400家机构组团调研",
            "features": {
                "keywords": [
                    "康龙化成",
                    "A股",
                    "下跌",
                    "机构",
                    "调研"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成A股跌逾14% 当日400家机构组团调研",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]